Advertisement
Advertisement

NRXS

NRXS logo

Neuraxis, Inc.

6.80
USD
Sponsored
-0.20
-2.86%
Jun 24, 16:00 UTC -4
Closed
exchange

After-Market

6.93

+0.13
+1.97%

Neuraxis, Inc. Profile

About

NeurAxis, Inc. is a medical technology company focused on neuromodulation therapies to address chronic and debilitating conditions in children and adults. NeurAxis, Inc. is based in CARMEL, Ind.

Info & Links

CEO

Brian Carrico

Headquarters

11611 N. Meridian Street, Suite 330
Carmel, IN 46032, UNITED STATES

Industry

Medical Info Systems

Sector

Medical

Website

https://neuraxis.com

Auditor

Rosenberg Rich Baker Berman, P.A.

Share holders

--

Employees

24

Neuraxis, Inc. Statistics

Valuation Measures

Market Capitalization2

85.87M

Enterprise Value

78.90M

Enterprise Value/EBITDA(ttm)

-10.95

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

22.73

Price to Book(mrq)

22.75

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

84.18%

Operating Margin(ttm)

-224.54%

Profit Margin(ttm)

-243.31%

Return on Equity(ttm)

-314.92%

Return on Invested Capital(ttm)

-1064.49%

Return on Assets(ttm)

-143.76%

Income Statement

Revenue(ttm)

4.28M

Revenue Per Share(ttm)

0.35

Gross Profit(ttm)

3.64M

EBITDA(ttm)3

-7.21M

Net Income Available to Common(ttm)

-8.07M

Diluted EPS(ttm)

-0.94

Share Statistics

Beta (5Y Monthly)

1.89

52-Week Change

186.92%

S&P 500 52-Week Change

20.78%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

12.38M

Dividend Yield

0.00%

Float4

8.23M

% Held by Insiders

26.40%

% Held by Institutions

11.77%

Balance Sheet

Total Cash(mrq)

7.08M

Total Cash Per Share(mrq)

0.57

Total Debt(mrq)

100.70K

Total Debt/Equity(mrq)

4.36%

Current Ratio(mrq)

2.05%

Quick Ratio(mrq)

1.96%

Book Value Per Share(mrq)

0.32

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.71

Free Cash Flow(ytd)

-6.46M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement